Uganda Expands Rollout of Six-Month HIV Prevention Injection Lenacapavir
Uganda has expanded the distribution of Lenacapavir, a long-acting HIV prevention injection, to over 104 health facilities. The rollout prioritizes pregnant and breastfeeding women due to limited global supply and high demand.
Why it matters
This initiative represents a significant advancement in HIV prevention, offering a more manageable alternative to daily oral medication for high-risk populations.
Uganda has intensified the rollout of Lenacapavir (LEN), a long-acting HIV prevention injection administered once every six months, as health authorities seek to reduce new HIV infections, particularly among populations at higher risk.
The article provides a factual report on public health policy and distribution logistics without emotive language.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in